100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study

Dr. Andrea Cercek, one of the lead researchers, said:Show more

“It’s absolutely incredible ... We’ve certainly never seen this before.”

All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody.

This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies.

The authors wrote:

“All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging ... and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.”

How does this monoclonal antibody actually work?

Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

Watch the Full Video: https://bit.ly/100-percent-cancer-remission